NRX Pharmaceuticals, Inc. Accrued Liabilities, Current
NRX Pharmaceuticals, Inc. (NRXP) had Accrued Liabilities, Current of $5.30 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2024-05-14
- 2024-03-31: Accrued Liabilities, Current $5.30M.
- 2023-12-31: Accrued Liabilities, Current $4.71M.
- 2023-09-30: Accrued Liabilities, Current $4.73M.
- 2023-06-30: Accrued Liabilities, Current $5.78M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2024-03-31 | $5.30M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $4.71M 10-Q · filed 2024-05-14 |
| 2023-09-30 | $4.73M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $5.78M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $5.05M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $4.86M 10-K · filed 2024-03-29 |
| 2022-09-30 | $5.07M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $3.33M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $4.00M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $2.38M 10-K · filed 2023-03-31 |
| 2021-09-30 | $2.00M 10-Q/A · filed 2022-08-12 |
| 2021-06-30 | $1.51M 10-Q/A · filed 2022-08-12 |
| 2020-12-31 | $1.73M 10-Q/A · filed 2022-08-12 |
| 2018-12-31 | $0.00 10-K · filed 2019-03-15 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-08 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-15 |
| 2017-12-31 | $7.50K 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |